Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.0001 USD | -.--% |
|
-.--% | +9’900.00% |
2023 | Regenicin, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. März 2023 | CI |
2023 | Regenicin, Inc. meldet Ergebnis für das erste Quartal zum 31. Dezember 2022 | CI |
Performance
1 Jahr | -95.24% | ||
3 Jahre | -99.62% | ||
5 Jahre | -99.49% | ||
10 Jahre | -99.00% |
Volumen
MärkteBasisdaten
Extremkurse
![Kursextrem 0.0001](/images/extremecours_fleche.png)
![Kursextrem 0](/images/extremecours_fleche.png)
![Kursextrem 0](/images/extremecours_fleche.png)
![Kursextrem 0](/images/extremecours_fleche.png)
![Kursextrem 0](/images/extremecours_fleche.png)
Indikatoren
Sektorenvergleich - Bio-Therapeutische Medikamente
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
-.--% | -.--% | - | -95.24% | 15’348 | ||
-0.80% | +0.00% | +15.20% | +34.62% | 121 Mrd. | ||
+0.02% | -0.20% | +19.67% | +48.36% | 113 Mrd. | ||
-1.87% | +9.90% | +18.95% | +15.46% | 26.02 Mrd. | ||
-0.02% | -5.06% | -23.86% | -24.90% | 19.39 Mrd. | ||
-1.88% | -3.38% | -19.03% | -31.16% | 15.91 Mrd. | ||
-2.00% | -8.61% | -20.90% | -20.11% | 15.09 Mrd. | ||
-0.36% | -3.21% | -46.14% | -36.61% | 15.06 Mrd. | ||
+0.03% | -1.69% | +63.85% | +40.77% | 14.93 Mrd. | ||
+2.50% | +2.30% | +4.49% | +45.70% | 13.85 Mrd. | ||
+0.07% | -1.46% | +116.20% | +229.72% | 10.8 Mrd. | ||
+2.65% | +16.29% | +139.15% | +276.58% | 9.06 Mrd. | ||
-4.14% | +0.76% | +20.24% | +55.66% | 8.22 Mrd. | ||
-0.83% | +3.94% | -26.39% | -36.91% | 8.07 Mrd. | ||
+0.72% | +6.67% | +8.28% | +55.86% | 7.82 Mrd. | ||
+0.96% | -1.82% | -3.56% | +28.58% | 7.45 Mrd. | ||
Durchschnitt | -0.31% | +0.91% | +17.74% | +36.65% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | -0.44% | +0.30% | +15.54% | +37.63% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | +9’900.00% | ||
2023 | -99.80% | ||
2022 | -95.00% | ||
2021 | -33.99% | ||
2020 | +43.60% | ||
2019 | -33.65% | ||
2018 | -87.28% | ||
2017 | +8.70% | ||
2016 | +450.24% | ||
2015 | -27.93% | ||
2014 | -3.33% | ||
2013 | -64.29% | ||
2012 | +5.00% | ||
2011 | -86.67% | ||
2010 | +1’919.86% | ||
2009 | -.--% |
- Börse
- Aktien
- A1C4ZE Aktie
- Kurse Regenicin, Inc.